Data is not available at this time.
Gooch & Housego PLC is a specialized manufacturer of advanced optical and photonic components, serving high-tech industries such as aerospace & defense, life sciences, and industrial applications. The company’s product portfolio includes acousto-optic modulators, fiber optics, precision lenses, and vision systems, catering to mission-critical applications in semiconductor manufacturing, telecommunications, and scientific research. Its expertise in niche optical technologies positions it as a key supplier to sectors requiring precision and reliability. Operating globally, Gooch & Housego leverages its UK-based R&D and manufacturing capabilities to maintain a competitive edge in high-growth markets like biophotonics and defense. The company’s diversified segment exposure mitigates sector-specific risks while allowing it to capitalize on technological advancements in laser systems and optical instrumentation. Its long-standing reputation, dating back to 1948, reinforces its credibility among OEMs and research institutions, though it faces competition from larger photonics firms and pricing pressures in commoditized segments.
In FY 2024, Gooch & Housego reported revenue of £136.0 million but recorded a net loss of £6.4 million, reflecting margin pressures or one-time charges. Operating cash flow of £14.2 million suggests underlying operational efficiency, though capital expenditures of £3.5 million indicate moderate reinvestment needs. The diluted EPS of -24p underscores profitability challenges, likely tied to input costs or R&D spend.
The company’s negative net income and EPS highlight near-term earnings volatility, possibly due to project timing or sector-specific demand fluctuations. However, positive operating cash flow signals cash-generative operations, with potential for margin recovery if cost structures stabilize. Capital expenditures remain disciplined, aligning with maintenance rather than aggressive expansion.
Gooch & Housego holds £6.6 million in cash against £32.4 million of total debt, indicating a leveraged position. The balance sheet may require monitoring, especially if interest rates rise or operating performance weakens further. The absence of liquidity crises is supported by positive cash flow, but debt servicing could constrain flexibility in downturns.
Despite profitability challenges, the company maintained a dividend of 13.2p per share, signaling commitment to shareholder returns. Growth prospects hinge on demand from defense and biophotonics sectors, though revenue stagnation in FY 2024 suggests near-term headwinds. Long-term opportunities in optical innovation remain a potential catalyst.
With a market cap of £133.6 million and a beta of 0.42, the stock is perceived as less volatile than the broader market. The valuation likely reflects skepticism around near-term earnings, balanced by niche market positioning and dividend yield. Investors may be pricing in a turnaround or sector recovery.
Gooch & Housego’s strengths lie in its specialized optical expertise and diversified industrial exposure. Challenges include navigating supply chain costs and competition in commoditized segments. The outlook depends on execution in high-margin niches like aerospace and biophotonics, where technological differentiation can drive pricing power and sustained growth.
Company filings, London Stock Exchange data
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |